XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1

SEGMENT INFORMATION (Tables)

9 Months Ended

Jul. 31, 2024

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

 SCHEDULE OF SEGMENT INFORMATION

		For the Three Months Ended July 31,								For the Nine Months Ended July 31,
		2024				2023				2024				2023
Net loss:
CAR-T Therapeutics		$	(1,145	)		$	(1,091	)		$	(4,115	)		$	(2,999	)
Cancer Vaccines			(2,160	)			(1,390	)			(5,628	)			(3,261	)
Other			(10	)			(67	)			(42	)			(949	)
Total		$	(3,315	)		$	(2,548	)		$	(9,785	)		$	(7,209	)
Net income/(loss)		$	(3,315	)		$	(2,548	)		$	(9,785	)		$	(7,209	)
Total operating costs and expenses		$	3,592			$	2,844			$	10,668			$	8,170
Less non-cash stock-based compensation			(1,179	)			(1,217	)			(3,699	)			(3,507	)
Operating costs and expenses excluding non-cash stock-based compensation		$	2,413			$	1,627			$	6,969			$	4,663
Operating costs and expenses excluding non-cash stock-based compensation:
CAR-T Therapeutics		$	789			$	713			$	2,943			$	1,930
Cancer Vaccines			1,614				855				3,988				1,966
Other			10				59				38				767
Total		$	2,413			$	1,627			$	6,969			$	4,663
Operating costs and expenses excluding non-cash stock-based compensation		$	2,413			$	1,627			$	6,969			$	4,663

		July 31, 2024				October 31, 2023
Total assets:
CAR-T Therapeutics		$	7,493			$	7,523
Cancer Vaccines			15,290				17,215
Other			125				784
Total		$	22,908			$	25,522
Total assets		$	22,908			$	25,522

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration